{
    "id": "dbpedia_219_3",
    "rank": 35,
    "data": {
        "url": "https://www.pnas.org/doi/abs/10.1073/pnas.1708252114",
        "read_more_link": "",
        "language": "en",
        "title": "CD1b-restricted GEM T cell responses are modulated by Mycobacterium tuberculosis mycolic acid meromycolate chains",
        "top_image": "https://www.pnas.org/cms/asset/cc25bca9-bd3b-4363-badf-f01eaad458b3/pnas.2017.114.issue-51.largecover.png",
        "meta_img": "https://www.pnas.org/cms/asset/cc25bca9-bd3b-4363-badf-f01eaad458b3/pnas.2017.114.issue-51.largecover.png",
        "images": [
            "https://www.pnas.org/pb-assets/images/Logos/header-logo/logo-1624644560537.svg",
            "https://www.pnas.org/pb-assets/images/Logos/header-logo/logo-light-1641218818190.svg",
            "https://www.pnas.org/pb-assets/images/Logos/header-logo/logo-1624644560537.svg",
            "https://www.pnas.org/pb-assets/images/icons/twitter-x-gray-1705527808743.svg",
            "https://www.pnas.org/pb-assets/images/icons/researcher-gray-1705530250737.svg",
            "https://www.pnas.org/cms/asset/6f5cde9f-76a2-47ae-a53a-d845d581ad20/pnas.2017.114.issue-51.cover.gif",
            "https://www.pnas.org/cms/asset/cc25bca9-bd3b-4363-badf-f01eaad458b3/pnas.2017.114.issue-51.largecover.png",
            "https://www.pnas.org/pb-assets/images/Logos/footer/logo-footer-1624408444100.svg"
        ],
        "movies": [
            "https://iframe.videodelivery.net/eyJraWQiOiI3YjgzNTg3NDZlNWJmNDM0MjY5YzEwZTYwMDg0ZjViYiIsImFsZyI6IlJTMjU2In0.eyJzdWIiOiJhYjAyY2M2NGFlMGYwNTQxMzFmYmM4ZmYxNWFhYWJjYiIsImV4cCI6MTcyMzUwMDI1OSwia2lkIjoiN2I4MzU4NzQ2ZTViZjQzNDI2OWMxMGU2MDA4NGY1YmIifQ.P-zQnxja7MIsuPkH5wDzeSz0bQ5WCernCSI9s4L7d-xR_cTRyEX-WlShqYWT5kZPmSl_cLpSep8Yg_i8tJOqAz4JM0n2EAg4i5avyG35UBRoN5o_RppEJii41FBSW3XbnJp8qvLx2uG-ty8Jpj21S5vCm7QAJ1yUXNuBXE0eTaq1vCOByqzohVbdPX7GAtLMQKK-A72R3RDvUm0Xhyxj5vyqIYvakOzweU_MDCry20XmpOo2oicL1PUMAU_9i644FpPw0aQ7JSgSx0Qqy_LOjXB_3YlgbCh5wvPuhLlLUkIdx3sspBGoRCy7F6cd8938JA6aCuPgq-Mf9bZH5QwG3w?poster=https%3A%2F%2Fvideodelivery.net%2FeyJraWQiOiI3YjgzNTg3NDZlNWJmNDM0MjY5YzEwZTYwMDg0ZjViYiIsImFsZyI6IlJTMjU2In0.eyJzdWIiOiJhYjAyY2M2NGFlMGYwNTQxMzFmYmM4ZmYxNWFhYWJjYiIsImV4cCI6MTcyMzUwMDI1OSwia2lkIjoiN2I4MzU4NzQ2ZTViZjQzNDI2OWMxMGU2MDA4NGY1YmIifQ.P-zQnxja7MIsuPkH5wDzeSz0bQ5WCernCSI9s4L7d-xR_cTRyEX-WlShqYWT5kZPmSl_cLpSep8Yg_i8tJOqAz4JM0n2EAg4i5avyG35UBRoN5o_RppEJii41FBSW3XbnJp8qvLx2uG-ty8Jpj21S5vCm7QAJ1yUXNuBXE0eTaq1vCOByqzohVbdPX7GAtLMQKK-A72R3RDvUm0Xhyxj5vyqIYvakOzweU_MDCry20XmpOo2oicL1PUMAU_9i644FpPw0aQ7JSgSx0Qqy_LOjXB_3YlgbCh5wvPuhLlLUkIdx3sspBGoRCy7F6cd8938JA6aCuPgq-Mf9bZH5QwG3w%2Fthumbnails%2Fthumbnail.jpg%3Ftime%3D10.0s",
            "https://iframe.videodelivery.net/eyJraWQiOiI3YjgzNTg3NDZlNWJmNDM0MjY5YzEwZTYwMDg0ZjViYiIsImFsZyI6IlJTMjU2In0.eyJzdWIiOiJmOWIwOTEyYzI1YmEyOGI0ZjhlODViNDg0Zjc5ZjU1MiIsImV4cCI6MTcyMzUwMDI1OSwia2lkIjoiN2I4MzU4NzQ2ZTViZjQzNDI2OWMxMGU2MDA4NGY1YmIifQ.MhnWRZKgHKAPNYnyedn2yCt2XfkGLL3V2Pvf5e9uCI5wWXP69ZqGu34Z5XMAMTZeKJgX1KXt5GsZHnQZPYWTPT9M1BWVNI-08EdFd4LpvO4-KfnVeKWQBTupiCPpPowQQpc96pULgqrMrfYaLMJTq1pzdFqt4eiGkuXwGsLoYYFv2gwJFVWust27yCTEB3HOtCm0UqjHgsZ81vcM9crZZgjRPcdEo-UgQGvHa8giX-FB0okkQO5QrJguKCCRyuewNpiI6aDy9ATbYQRexWFUVDwtZtInO3H9zFxaJ_CyIs1o7Zxu_OpsZfqK1YSonwt6g4UavO8_ttVNP8NPrEMclw?poster=https%3A%2F%2Fvideodelivery.net%2FeyJraWQiOiI3YjgzNTg3NDZlNWJmNDM0MjY5YzEwZTYwMDg0ZjViYiIsImFsZyI6IlJTMjU2In0.eyJzdWIiOiJmOWIwOTEyYzI1YmEyOGI0ZjhlODViNDg0Zjc5ZjU1MiIsImV4cCI6MTcyMzUwMDI1OSwia2lkIjoiN2I4MzU4NzQ2ZTViZjQzNDI2OWMxMGU2MDA4NGY1YmIifQ.MhnWRZKgHKAPNYnyedn2yCt2XfkGLL3V2Pvf5e9uCI5wWXP69ZqGu34Z5XMAMTZeKJgX1KXt5GsZHnQZPYWTPT9M1BWVNI-08EdFd4LpvO4-KfnVeKWQBTupiCPpPowQQpc96pULgqrMrfYaLMJTq1pzdFqt4eiGkuXwGsLoYYFv2gwJFVWust27yCTEB3HOtCm0UqjHgsZ81vcM9crZZgjRPcdEo-UgQGvHa8giX-FB0okkQO5QrJguKCCRyuewNpiI6aDy9ATbYQRexWFUVDwtZtInO3H9zFxaJ_CyIs1o7Zxu_OpsZfqK1YSonwt6g4UavO8_ttVNP8NPrEMclw%2Fthumbnails%2Fthumbnail.jpg%3Ftime%3D10.0s",
            "https://iframe.videodelivery.net/eyJraWQiOiI3YjgzNTg3NDZlNWJmNDM0MjY5YzEwZTYwMDg0ZjViYiIsImFsZyI6IlJTMjU2In0.eyJzdWIiOiI5MDg3NTI2NTllNGJmZDc0ZjRhZDBmNmI5YmNjMjVlNyIsImV4cCI6MTcyMzUwMDI1OSwia2lkIjoiN2I4MzU4NzQ2ZTViZjQzNDI2OWMxMGU2MDA4NGY1YmIifQ.YEss4CLY9oYwQxDERL_yxY9RoajfIiczaw5GfyZ-YKpvOHzV9I_zC7lTb-jK5wjuOQLjhdqiOUAz8d3ElWjiNUx9PjwbI45HPk80-elHiksF8f4SvjEoRZ3ll8bINq4NlR0fNGM6wqZVQ3H6OElJNScmDc0itokMACSDUkGZibAOqWOfJ8vkin-174CcyZ0hiYK9W0W65Depq1nU7x7vcyy8sdf-Dts7oRYlNo-o5HgRW5eqdFuf3U3ofaXa3c2LpPR4qoVOS8prIuQoMhALkVDdTHCDygVqK4GtDSwHbystF47clzeiWedmO21VfL5FGRZhNs0KzXHIEMVK_gIuRQ?poster=https%3A%2F%2Fvideodelivery.net%2FeyJraWQiOiI3YjgzNTg3NDZlNWJmNDM0MjY5YzEwZTYwMDg0ZjViYiIsImFsZyI6IlJTMjU2In0.eyJzdWIiOiI5MDg3NTI2NTllNGJmZDc0ZjRhZDBmNmI5YmNjMjVlNyIsImV4cCI6MTcyMzUwMDI1OSwia2lkIjoiN2I4MzU4NzQ2ZTViZjQzNDI2OWMxMGU2MDA4NGY1YmIifQ.YEss4CLY9oYwQxDERL_yxY9RoajfIiczaw5GfyZ-YKpvOHzV9I_zC7lTb-jK5wjuOQLjhdqiOUAz8d3ElWjiNUx9PjwbI45HPk80-elHiksF8f4SvjEoRZ3ll8bINq4NlR0fNGM6wqZVQ3H6OElJNScmDc0itokMACSDUkGZibAOqWOfJ8vkin-174CcyZ0hiYK9W0W65Depq1nU7x7vcyy8sdf-Dts7oRYlNo-o5HgRW5eqdFuf3U3ofaXa3c2LpPR4qoVOS8prIuQoMhALkVDdTHCDygVqK4GtDSwHbystF47clzeiWedmO21VfL5FGRZhNs0KzXHIEMVK_gIuRQ%2Fthumbnails%2Fthumbnail.jpg%3Ftime%3D10.0s",
            "https://iframe.videodelivery.net/eyJraWQiOiI3YjgzNTg3NDZlNWJmNDM0MjY5YzEwZTYwMDg0ZjViYiIsImFsZyI6IlJTMjU2In0.eyJzdWIiOiI3NDM1YzI1YWFjOWUwNTIzNzYzZDA4NTkxM2QyYzZkNSIsImV4cCI6MTcyMzUwMDI1OSwia2lkIjoiN2I4MzU4NzQ2ZTViZjQzNDI2OWMxMGU2MDA4NGY1YmIifQ.yZTV-mqwB2m5Y0e8vsgBMRYIUhvndy_L-H-gXwoxjAeeantF65brJZ1TielF4rATQl7ewd8J53OE_wG5mSWn8UqGCSi2Io_CLW5A-l1YBVkQK3-Fy6bnCmI722IvUTJrHP7-LspQjfqD7RcnwzF1UQar2iA6J2npQxfENJOwTrzhKdwtywcNui2HWcguMUyy0MuVHTh4FFwSFsPFE0-fRcYKM8X_YHcMTvovwwnrhND6K3yUtGMHaRHJ7RUWVaPrtTj7oaRTqloBKACUblZJ3DxHl2x6ppnIriIZ2OwB4RiYIFn6p5UcEN4PPLa5QgDdsZI1T4nyCOd3CVGlGrgRow?poster=https%3A%2F%2Fvideodelivery.net%2FeyJraWQiOiI3YjgzNTg3NDZlNWJmNDM0MjY5YzEwZTYwMDg0ZjViYiIsImFsZyI6IlJTMjU2In0.eyJzdWIiOiI3NDM1YzI1YWFjOWUwNTIzNzYzZDA4NTkxM2QyYzZkNSIsImV4cCI6MTcyMzUwMDI1OSwia2lkIjoiN2I4MzU4NzQ2ZTViZjQzNDI2OWMxMGU2MDA4NGY1YmIifQ.yZTV-mqwB2m5Y0e8vsgBMRYIUhvndy_L-H-gXwoxjAeeantF65brJZ1TielF4rATQl7ewd8J53OE_wG5mSWn8UqGCSi2Io_CLW5A-l1YBVkQK3-Fy6bnCmI722IvUTJrHP7-LspQjfqD7RcnwzF1UQar2iA6J2npQxfENJOwTrzhKdwtywcNui2HWcguMUyy0MuVHTh4FFwSFsPFE0-fRcYKM8X_YHcMTvovwwnrhND6K3yUtGMHaRHJ7RUWVaPrtTj7oaRTqloBKACUblZJ3DxHl2x6ppnIriIZ2OwB4RiYIFn6p5UcEN4PPLa5QgDdsZI1T4nyCOd3CVGlGrgRow%2Fthumbnails%2Fthumbnail.jpg%3Ftime%3D10.0s"
        ],
        "keywords": [],
        "meta_keywords": [
            "Mycobacterium tuberculosis",
            "GEM T cells",
            "CD1b",
            "mycolate lipids",
            "molecular dynamics"
        ],
        "tags": null,
        "authors": [
            "this author",
            "Susan Wilson",
            "Nikolai M. Lissin",
            "Marc Tebruegge",
            "Ben Marshall",
            "Sally Sharpe",
            "Tim Elliott",
            "Chris-Kriton Skylaris",
            "Jonathan W. Essex",
            "Mark S. Baird"
        ],
        "publish_date": null,
        "summary": "",
        "meta_description": "Tuberculosis (TB), caused by Mycobacterium tuberculosis, remains a major human pandemic.\nGermline-encoded mycolyl lipid-reactive (GEM) T cells are ...",
        "meta_lang": "en",
        "meta_favicon": "/products/pnas/releasedAssets/images/favicon/favicon-f7229df5ea4aa1e206bbb00228dc8de4.ico",
        "meta_site_name": "PNAS",
        "canonical_link": "https://www.pnas.org/doi/abs/10.1073/pnas.1708252114",
        "text": "Significance\n\nTuberculosis is a major global pandemic responsible for more deaths than any other infectious disease, yet no effective vaccine exists. Here, we demonstrate CD1b expression within human tuberculous granulomas, supporting a role for CD1b lipid antigen presentation in host immunity to infection. CD1b presents mycolates, the dominant Mycobacterium tuberculosis (Mtb) cell wall lipid class and key virulence factors, to αβ T cells. We reveal that mycolate tail moieties, distal to the head group, are antigenic determinants for the conserved human germline-encoded mycolyl lipid-reactive (GEM) T cell receptors (TCRs). Computational simulations suggest a putative mechanism whereby lipid-ligand dynamics within CD1b regulate GEM-TCR activity. This work provides insights for the development of major histocompatibility complex (MHC)-independent Mtb lipid vaccines, including those that target GEM T cells.\n\nAbstract\n\nTuberculosis (TB), caused by Mycobacterium tuberculosis, remains a major human pandemic. Germline-encoded mycolyl lipid-reactive (GEM) T cells are donor-unrestricted and recognize CD1b-presented mycobacterial mycolates. However, the molecular requirements governing mycolate antigenicity for the GEM T cell receptor (TCR) remain poorly understood. Here, we demonstrate CD1b expression in TB granulomas and reveal a central role for meromycolate chains in influencing GEM-TCR activity. Meromycolate fine structure influences T cell responses in TB-exposed individuals, and meromycolate alterations modulate functional responses by GEM-TCRs. Computational simulations suggest that meromycolate chain dynamics regulate mycolate head group movement, thereby modulating GEM-TCR activity. Our findings have significant implications for the design of future vaccines that target GEM T cells.\n\nContinue Reading\n\nAcknowledgments\n\nWe thank Richard Jewell and Carolann McGuire for their assistance with flow cytometry (FACS facility, Faculty of Medicine, University of Southampton), Jenny Norman (Histochemistry Research Unit) for undertaking the immunohistochemical staining, and Sanjay Jogai for providing the reagents for immunohistochemistry. Special thanks to Joseph Sanderson, Andrew Gerry, and Bent Jakobsen for advice and support in generating GEM-TCR–transduced T cell lines. We also thank Liselotte Brix, Andreas Fløe Nielsen, and Bjarke Endel Hansen for generous provision of dextran backbone, CD1b monomers, and support in generating soluble fluorescent dextramers. Many thanks to Akul Singhania for production of the heat map and for statistical support. This work was supported by Public Health England, US NIH Grant R33AI102239, UK Medical Research Council Grant MR/N006631/1, and Cancer Research UK Grant A23562.\n\nSupporting Information\n\nSupporting Information (PDF)\n\nDownload\n\n3.09 MB\n\nMovie S1.\n\nMolecular dynamics trajectory of CD1b bound to the stimulatory α-MA JR1080.\n\nDownload\n\n37.03 MB\n\nMovie S2.\n\nMolecular dynamics trajectory of CD1b bound to the weakly stimulatory transmethoxy-MA JRRR121.\n\nDownload\n\n38.36 MB\n\nMovie S3.\n\nMolecular dynamics trajectory showing a close-up of the distal functional methoxy group of the weakly stimulatory transmethoxy-MA JRRR121 remaining relatively fixed within a crevice of the binding pocket of CD1b.\n\nDownload\n\n36.61 MB\n\nMovie S4.\n\nMolecular dynamics trajectory of CD1b with an overlay of two bound lipids. The strongly stimulatory MA MH157 (proximal functional group indicated in yellow) and the weakly stimulatory transmethoxy-MA JRRR121 (proximal functional group indicated in red) within the binding pocket of CD1b are shown. MH157 exhibits much greater movement within the groove than JRRR121.\n\nDownload\n\n38.36 MB\n\nReferences\n\n1\n\nRS Wallis, et al., Tuberculosis–Advances in development of new drugs, treatment regimens, host-directed therapies, and biomarkers. Lancet Infect Dis 16, e34–e46 (2016).\n\n2\n\nP Nguipdop-Djomo, E Heldal, LC Rodrigues, I Abubakar, P Mangtani, Duration of BCG protection against tuberculosis and change in effectiveness with time since vaccination in Norway: A retrospective population-based cohort study. Lancet Infect Dis 16, 219–226 (2016).\n\n3\n\nA O’Garra, et al., The immune response in tuberculosis. Annu Rev Immunol 31, 475–527 (2013).\n\n4\n\nLD Jasenosky, TJ Scriba, WA Hanekom, AE Goldfeld, T cells and adaptive immunity to Mycobacterium tuberculosis in humans. Immunol Rev 264, 74–87 (2015).\n\n5\n\nMD Tameris, et al., Safety and efficacy of MVA85A, a new tuberculosis vaccine, in infants previously vaccinated with BCG: A randomised, placebo-controlled phase 2b trial. Lancet; MVA85A 020 Trial Study Team 381, 1021–1028 (2013).\n\n6\n\nBP Ndiaye, et al., Safety, immunogenicity, and efficacy of the candidate tuberculosis vaccine MVA85A in healthy adults infected with HIV-1: A randomised, placebo-controlled, phase 2 trial. Lancet Respir Med; MVA85A 030 trial investigators 3, 190–200 (2015).\n\n7\n\nCL Karp, CB Wilson, LM Stuart, Tuberculosis vaccines: Barriers and prospects on the quest for a transformative tool. Immunol Rev 264, 363–381 (2015).\n\n8\n\nPJ Brennan, H Nikaido, The envelope of mycobacteria. Annu Rev Biochem 64, 29–63 (1995).\n\n9\n\nI Van Rhijn, et al., A conserved human T cell population targets mycobacterial antigens presented by CD1b. Nat Immunol 14, 706–713 (2013).\n\n10\n\nAG Kasmar, et al., CD1b tetramers bind αβ T cell receptors to identify a mycobacterial glycolipid-reactive T cell repertoire in humans. J Exp Med 208, 1741–1747 (2011).\n\n11\n\nJP Rosat, et al., CD1-restricted microbial lipid antigen-specific recognition found in the CD8+ alpha beta T cell pool. J Immunol 162, 366–371 (1999).\n\n12\n\nDB Moody, et al., CD1c-mediated T-cell recognition of isoprenoid glycolipids in Mycobacterium tuberculosis infection. Nature 404, 884–888 (2000).\n\n13\n\nI Matsunaga, M Sugita, Mycoketide: A CD1c-presented antigen with important implications in mycobacterial infection. Clin Dev Immunol 2012, 981821 (2012).\n\n14\n\nM Brigl, MB Brenner, CD1: Antigen presentation and T cell function. Annu Rev Immunol 22, 817–890 (2004).\n\n15\n\nDB Moody, et al., CD1b-mediated T cell recognition of a glycolipid antigen generated from mycobacterial lipid and host carbohydrate during infection. J Exp Med 192, 965–976 (2000).\n\n16\n\nM Gilleron, et al., Diacylated sulfoglycolipids are novel mycobacterial antigens stimulating CD1-restricted T cells during infection with Mycobacterium tuberculosis. J Exp Med 199, 649–659 (2004).\n\n17\n\nWA Ernst, et al., Molecular interaction of CD1b with lipoglycan antigens. Immunity 8, 331–340 (1998).\n\n18\n\nDJ Montamat-Sicotte, et al., A mycolic acid-specific CD1-restricted T cell population contributes to acute and memory immune responses in human tuberculosis infection. J Clin Invest 121, 2493–2503 (2011).\n\n19\n\nJ Zhao, et al., Mycolic acid-specific T cells protect against Mycobacterium tuberculosis infection in a humanized transgenic mouse model. Elife 4, e08525 (2015).\n\n20\n\nM Busch, et al., Lipoarabinomannan-responsive polycytotoxic T cells are associated with protection in human tuberculosis. Am J Respir Crit Care Med; TBornotTB Network 194, 345–355 (2016).\n\n21\n\nS Vander Beken, et al., Molecular structure of the Mycobacterium tuberculosis virulence factor, mycolic acid, determines the elicited inflammatory pattern. Eur J Immunol 41, 450–460 (2011).\n\n22\n\nJA Verschoor, MS Baird, J Grooten, Towards understanding the functional diversity of cell wall mycolic acids of Mycobacterium tuberculosis. Prog Lipid Res 51, 325–339 (2012).\n\n23\n\nEM Beckman, et al., Recognition of a lipid antigen by CD1-restricted alpha beta+ T cells. Nature 372, 691–694 (1994).\n\n24\n\nG Sekanka, M Baird, D Minnikin, J Grooten, Mycolic acids for the control of tuberculosis. Expert Opin Ther Pat 17, 315–331 (2007).\n\n25\n\nT Batuwangala, et al., The crystal structure of human CD1b with a bound bacterial glycolipid. J Immunol 172, 2382–2388 (2004).\n\n26\n\nI Van Rhijn, et al., TCR bias and affinity define two compartments of the CD1b-glycolipid-specific T cell repertoire. J Immunol 192, 4054–4060 (2014).\n\n27\n\nDB Moody, et al., Structural requirements for glycolipid antigen recognition by CD1b-restricted T cells. Science 278, 283–286 (1997).\n\n28\n\nMS Inkeles, et al., Cell-type deconvolution with immune pathways identifies gene networks of host defense and immunopathology in leprosy. JCI Insight 1, e88843 (2016).\n\n29\n\nPA Sieling, et al., CD1 expression by dendritic cells in human leprosy lesions: Correlation with effective host immunity. J Immunol 162, 1851–1858 (1999).\n\n30\n\nS Stenger, KR Niazi, RL Modlin, Down-regulation of CD1 on antigen-presenting cells by infection with Mycobacterium tuberculosis. J Immunol 161, 3582–3588 (1998).\n\n31\n\nS Gras, et al., T cell receptor recognition of CD1b presenting a mycobacterial glycolipid. Nat Commun 7, 13257 (2016).\n\n32\n\nSG Taher, M Muzael, JR Al Dulayymi, MS Baird, Synthetic trehalose esters of cis-alkene and diene α′-mycolic acids of Mycobacteria. Chem Phys Lipids 189, 28–38 (2015).\n\n33\n\nC Don Lawson, M Maza-Iglesias, MM Sirhan, JR Al Dulayymi, MS Baird, The synthesis of single enantiomers of α-mycolic acids of Mycobacterium tuberculosis and related organisms, with alternative cyclopropane stereochemistries. SynOpen 1, 103–116 (2017).\n\n34\n\nY Yuan, 3rd CE Barry, A common mechanism for the biosynthesis of methoxy and cyclopropyl mycolic acids in Mycobacterium tuberculosis. Proc Natl Acad Sci USA 93, 12828–12833 (1996).\n\n35\n\nC Seshadri, et al., T cell responses against mycobacterial lipids and proteins are poorly correlated in South African adolescents. J Immunol 195, 4595–4603 (2015).\n\n36\n\nI Van Rhijn, et al., CD1b-mycolic acid tetramers demonstrate T-cell fine specificity for mycobacterial lipid tails. Eur J Immunol 47, 1525–1534 (2017).\n\n37\n\nI Van Rhijn, DB Moody, Donor unrestricted T cells: A shared human T cell response. J Immunol 195, 1927–1932 (2015).\n\n38\n\nS Huang, DB Moody, Donor-unrestricted T cells in the human CD1 system. Immunogenetics 68, 577–596 (2016).\n\n39\n\nJ Guiard, et al., Fatty acyl structures of mycobacterium tuberculosis sulfoglycolipid govern T cell response. J Immunol 182, 7030–7037 (2009).\n\n40\n\nA de Jong, et al., CD1c presentation of synthetic glycolipid antigens with foreign alkyl branching motifs. Chem Biol 14, 1232–1242 (2007).\n\n41\n\nC McCarthy, et al., The length of lipids bound to human CD1d molecules modulates the affinity of NKT cell TCR and the threshold of NKT cell activation. J Exp Med 204, 1131–1144 (2007).\n\n42\n\nWF Hawse, et al., TCR scanning of peptide/MHC through complementary matching of receptor and ligand molecular flexibility. J Immunol 192, 2885–2891 (2014).\n\n43\n\nMA Flores-Valdez, RP Morris, F Laval, M Daffé, GK Schoolnik, Mycobacterium tuberculosis modulates its cell surface via an oligopeptide permease (Opp) transport system. FASEB J 23, 4091–4104 (2009).\n\n44\n\nM Watanabe, Y Aoyagi, M Ridell, DE Minnikin, Separation and characterization of individual mycolic acids in representative mycobacteria. Microbiology 147, 1825–1837 (2001).\n\n45\n\nEP Grant, et al., Fine specificity of TCR complementarity-determining region residues and lipid antigen hydrophilic moieties in the recognition of a CD1-lipid complex. J Immunol 168, 3933–3940 (2002).\n\n46\n\nS Gagneux, Host-pathogen coevolution in human tuberculosis. Philos Trans R Soc Lond B Biol Sci 367, 850–859 (2012).\n\n47\n\nS Mansour, et al., Cholesteryl esters stabilize human CD1c conformations for recognition by self-reactive T cells. Proc Natl Acad Sci USA 113, E1266–E1275 (2016).\n\n48\n\nT Dull, et al., A third-generation lentivirus vector with a conditional packaging system. J Virol 72, 8463–8471 (1998).\n\n49\n\nR Al Dulayymi Ja, et al., Synthetic trehalose di- and mono-esters of α-, methoxy- and keto-mycolic acids. Tetrahedron 70, 9836–9852 (2014).\n\n50\n\nDZ Al Kremawi, JR Al Dulayymi, MS Baird, Synthetic epoxy-mycolic acids. Tetrahedron 70, 7322–7335 (2014).\n\n51\n\nHM Ali, et al., The synthesis of single enantiomers of trans-alkene containing mycolic acids and related sugar esters. Tetrahedron 72, 7143–7158 (2016).\n\n52\n\nOT Ali, MM Sahb, JR Al Dulayymi, MS Baird, Glycerol mycolates from synthetic mycolic acids. Carbohydr Res 448, 67–73 (2017).\n\n53\n\nG Koza, et al., The synthesis of methoxy and keto mycolic acids containing methyl-trans-cyclopropanes. Tetrahedron 69, 6285–6296 (2013).\n\n54\n\nMM Sahb, JR Al Dulayymi, MS Baird, Glucose monomycolates based on single synthetic mycolic acids. Chem Phys Lipids 190, 9–14 (2015).\n\n55\n\nSD Gadola, et al., Structure of human CD1b with bound ligands at 2.3 A, a maze for alkyl chains. Nat Immunol 3, 721–726 (2002).\n\n56\n\n; Chemical Computing Group, Molecular Operating Environment (MOE) (Chemical Computing Group, Inc., Montreal). (2017).\n\n57\n\nDA Case, et al., AMBER 2107 (University of California, San Francisco). (2016).\n\nInformation & Authors\n\nInformation\n\nPublished in\n\nProceedings of the National Academy of Sciences\n\nVol. 114 | No. 51\n\nDecember 19, 2017\n\nPubMed: 29158404\n\nClassifications\n\nCopyright\n\n© 2017. Published under the PNAS license.\n\nSubmission history\n\nPublished online: November 20, 2017\n\nPublished in issue: December 19, 2017\n\nKeywords\n\nMycobacterium tuberculosis\n\nGEM T cells\n\nCD1b\n\nmycolate lipids\n\nmolecular dynamics\n\nAcknowledgments\n\nWe thank Richard Jewell and Carolann McGuire for their assistance with flow cytometry (FACS facility, Faculty of Medicine, University of Southampton), Jenny Norman (Histochemistry Research Unit) for undertaking the immunohistochemical staining, and Sanjay Jogai for providing the reagents for immunohistochemistry. Special thanks to Joseph Sanderson, Andrew Gerry, and Bent Jakobsen for advice and support in generating GEM-TCR–transduced T cell lines. We also thank Liselotte Brix, Andreas Fløe Nielsen, and Bjarke Endel Hansen for generous provision of dextran backbone, CD1b monomers, and support in generating soluble fluorescent dextramers. Many thanks to Akul Singhania for production of the heat map and for statistical support. This work was supported by Public Health England, US NIH Grant R33AI102239, UK Medical Research Council Grant MR/N006631/1, and Cancer Research UK Grant A23562.\n\nNotes\n\nThis article is a PNAS Direct Submission.\n\nSee Commentary on page 13312.\n\nAuthors\n\nAffiliations\n\nAndrew Chancellor\n\nAcademic Unit of Clinical and Experimental Sciences, Faculty of Medicine, University of Southampton, Southampton SO16 6YD, United Kingdom;\n\nPublic Health England, National Infections Service, Porton Down, Salisbury SP4 0JQ, United Kingdom;\n\nAnna S. Tocheva\n\nAcademic Unit of Clinical and Experimental Sciences, Faculty of Medicine, University of Southampton, Southampton SO16 6YD, United Kingdom;\n\nPresent address: Department of Medicine, New York University School of Medicine, New York, NY 10016.\n\nChris Cave-Ayland\n\nSchool of Chemistry, University of Southampton, Southampton SO17 1BJ, United Kingdom;\n\nLiku Tezera\n\nAcademic Unit of Clinical and Experimental Sciences, Faculty of Medicine, University of Southampton, Southampton SO16 6YD, United Kingdom;\n\nAndrew White\n\nPublic Health England, National Infections Service, Porton Down, Salisbury SP4 0JQ, United Kingdom;\n\nJuma’a R. Al Dulayymi\n\nSchool of Chemistry, Bangor University, Bangor, Gwynedd LL57 2UW, United Kingdom;\n\nJohn S. Bridgeman\n\nCellular Therapeutics Ltd, Manchester M13 9XX, United Kingdom;\n\nIvo Tews\n\nSchool of Biological Sciences, University of Southampton, Southampton SO17 1BJ, United Kingdom;\n\nInstitute for Life Sciences, University of Southampton, Southampton SO17 1BJ, United Kingdom;\n\nSusan Wilson\n\nAcademic Unit of Clinical and Experimental Sciences, Faculty of Medicine, University of Southampton, Southampton SO16 6YD, United Kingdom;\n\nHistochemistry Unit, University of Southampton, Southampton SO16 6YD, United Kingdom;\n\nNikolai M. Lissin\n\nImmunocore Ltd., Abingdon, Oxon OX14 4RY, United Kingdom;\n\nMarc Tebruegge\n\nAcademic Unit of Clinical and Experimental Sciences, Faculty of Medicine, University of Southampton, Southampton SO16 6YD, United Kingdom;\n\nInstitute for Life Sciences, University of Southampton, Southampton SO17 1BJ, United Kingdom;\n\nNIHR Southampton Biomedical Research Centre, Southampton SO17 1BJ, United Kingdom;\n\nGlobal Health Research Institute, University of Southampton, Southampton SO17 1BJ, United Kingdom;\n\nDepartment of Paediatrics, Faculty of Medicine, University of Melbourne, 3052 Parkville, Australia;\n\nDepartment of Paediatric Infectious Diseases & Immunology, Evelina London Children’s Hospital, Guy’s and St. Thomas’ NHS Foundation Trust, London SE1 7EH, United Kingdom;\n\nBen Marshall\n\nAcademic Unit of Clinical and Experimental Sciences, Faculty of Medicine, University of Southampton, Southampton SO16 6YD, United Kingdom;\n\nInstitute for Life Sciences, University of Southampton, Southampton SO17 1BJ, United Kingdom;\n\nNIHR Southampton Biomedical Research Centre, Southampton SO17 1BJ, United Kingdom;\n\nSally Sharpe\n\nPublic Health England, National Infections Service, Porton Down, Salisbury SP4 0JQ, United Kingdom;\n\nTim Elliott\n\nInstitute for Life Sciences, University of Southampton, Southampton SO17 1BJ, United Kingdom;\n\nCancer Sciences Unit, Faculty of Medicine, University of Southampton, Southampton SO16 6YD, United Kingdom;\n\nChris-Kriton Skylaris\n\nSchool of Chemistry, University of Southampton, Southampton SO17 1BJ, United Kingdom;\n\nInstitute for Life Sciences, University of Southampton, Southampton SO17 1BJ, United Kingdom;\n\nJonathan W. Essex\n\nSchool of Chemistry, University of Southampton, Southampton SO17 1BJ, United Kingdom;\n\nInstitute for Life Sciences, University of Southampton, Southampton SO17 1BJ, United Kingdom;\n\nMark S. Baird\n\nSchool of Chemistry, Bangor University, Bangor, Gwynedd LL57 2UW, United Kingdom;\n\nStephan Gadola\n\nAcademic Unit of Clinical and Experimental Sciences, Faculty of Medicine, University of Southampton, Southampton SO16 6YD, United Kingdom;\n\nInstitute for Life Sciences, University of Southampton, Southampton SO17 1BJ, United Kingdom;\n\nF. Hoffmann-La Roche Ltd., 4070 Basel, Switzerland\n\nPaul Elkington\n\nAcademic Unit of Clinical and Experimental Sciences, Faculty of Medicine, University of Southampton, Southampton SO16 6YD, United Kingdom;\n\nInstitute for Life Sciences, University of Southampton, Southampton SO17 1BJ, United Kingdom;\n\nNIHR Southampton Biomedical Research Centre, Southampton SO17 1BJ, United Kingdom;\n\nGlobal Health Research Institute, University of Southampton, Southampton SO17 1BJ, United Kingdom;\n\nSalah Mansour2 [email protected]\n\nAcademic Unit of Clinical and Experimental Sciences, Faculty of Medicine, University of Southampton, Southampton SO16 6YD, United Kingdom;\n\nInstitute for Life Sciences, University of Southampton, Southampton SO17 1BJ, United Kingdom;\n\nNotes\n\n2\n\nTo whom correspondence should be addressed. Email: [email protected].\n\nAuthor contributions: A.C., S.G., and S.M. designed research; A.C., A.S.T., C.C.-A., L.T., A.W., J.R.A.D., N.M.L., T.E., C.-K.S., J.W.E., P.E., and S.M. performed research; J.R.A.D., J.S.B., S.W., N.M.L., M.T., B.M., M.S.B., and P.E. contributed new reagents/analytic tools; A.C., C.C.-A., L.T., A.W., J.S.B., I.T., S.W., M.T., B.M., S.S., T.E., C.-K.S., J.W.E., M.S.B., S.G., P.E., and S.M. analyzed data; and A.C. and S.M. wrote the paper.\n\nCompeting Interests\n\nThe authors declare no conflict of interest.\n\nMetrics & Citations\n\nMetrics\n\nNote: The article usage is presented with a three- to four-day delay and will update daily once available. Due to ths delay, usage data will not appear immediately following publication. Citation information is sourced from Crossref Cited-by service.\n\nCitation statements\n\nAltmetrics\n\nCitations\n\nIf you have the appropriate software installed, you can download article citation data to the citation manager of your choice. Simply select your manager software from the list below and click Download.\n\nFormat\n\nDirect Import\n\nCited by\n\nLoading...\n\nView Options\n\nView options\n\nPDF format\n\nDownload this article as a PDF file\n\nDOWNLOAD PDF\n\nGet Access\n\nLogin options\n\nCheck if you have access through your login credentials or your institution to get full access on this article.\n\nPersonal login Institutional Login\n\nRecommend to a librarian\n\nRecommend PNAS to a Librarian\n\nPurchase options\n\nPurchase this article to access the full text.\n\nSingle Article Purchase\n\nCD1b-restricted GEM T cell responses are modulated by Mycobacterium tuberculosis mycolic acid meromycolate chains\n\nProceedings of the National Academy of Sciences\n\nVol. 114\n\nNo. 51\n\npp. 13303-E11060\n\n$10.00\n\nRestore content access\n\nRestore content access for purchases made as a guest\n\nMedia\n\nFigures\n\nTables\n\nOther\n\nShare\n\nShare\n\nShare article link\n\nCopied!\n\nCopying failed.\n\nShare on social media\n\nOpen in viewer Request permissions"
    }
}